Ignite Creation Date:
2025-12-24 @ 11:11 PM
Ignite Modification Date:
2025-12-25 @ 8:44 PM
Study NCT ID:
NCT05185869
Status:
UNKNOWN
Last Update Posted:
2022-01-11
First Post:
2021-12-19
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
SHR6390 Plus Nab-paclitaxel and Gemcitabine in Advanced/Metastatic Pancreatic Cancer
Sponsor:
Ruijin Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-10
Completion Date Type:
ESTIMATED
First Submit Date:
2021-12-19
First Submit QC Date:
None
Study First Post Date:
2022-01-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-10
Last Update Post Date:
2022-01-11
Last Update Post Date Type:
ACTUAL